Free Trial

Lipella Pharmaceuticals (LIPO) Competitors

Lipella Pharmaceuticals logo
$0.63 -0.09 (-12.92%)
As of 01:06 PM Eastern

LIPO vs. TXMD, CSCI, ABP, TRIB, SNPX, GOVX, BCDA, ATNF, IMCC, and IBIO

Should you be buying Lipella Pharmaceuticals stock or one of its competitors? The main competitors of Lipella Pharmaceuticals include TherapeuticsMD (TXMD), COSCIENS Biopharma (CSCI), Abpro (ABP), Trinity Biotech (TRIB), Synaptogenix (SNPX), GeoVax Labs (GOVX), BioCardia (BCDA), 180 Life Sciences (ATNF), IM Cannabis (IMCC), and iBio (IBIO). These companies are all part of the "pharmaceutical products" industry.

Lipella Pharmaceuticals vs. Its Competitors

Lipella Pharmaceuticals (NASDAQ:LIPO) and TherapeuticsMD (NASDAQ:TXMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

TherapeuticsMD has a net margin of -114.07% compared to Lipella Pharmaceuticals' net margin of -988.83%. TherapeuticsMD's return on equity of -7.86% beat Lipella Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Lipella Pharmaceuticals-988.83% -224.08% -172.88%
TherapeuticsMD -114.07%-7.86%-5.46%

Lipella Pharmaceuticals has a beta of -0.08, meaning that its share price is 108% less volatile than the S&P 500. Comparatively, TherapeuticsMD has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500.

TherapeuticsMD has higher revenue and earnings than Lipella Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lipella Pharmaceuticals$536.36K5.22-$5.02M-$4.08-0.15
TherapeuticsMD$1.76M7.82-$2.18MN/AN/A

74.3% of Lipella Pharmaceuticals shares are owned by institutional investors. Comparatively, 30.7% of TherapeuticsMD shares are owned by institutional investors. 32.1% of Lipella Pharmaceuticals shares are owned by insiders. Comparatively, 2.3% of TherapeuticsMD shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Lipella Pharmaceuticals and Lipella Pharmaceuticals both had 1 articles in the media. TherapeuticsMD's average media sentiment score of 1.89 beat Lipella Pharmaceuticals' score of 0.59 indicating that TherapeuticsMD is being referred to more favorably in the news media.

Company Overall Sentiment
Lipella Pharmaceuticals Positive
TherapeuticsMD Very Positive

Summary

TherapeuticsMD beats Lipella Pharmaceuticals on 8 of the 10 factors compared between the two stocks.

Get Lipella Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIPO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIPO vs. The Competition

MetricLipella PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.80M$3.07B$5.70B$9.51B
Dividend YieldN/A2.36%4.69%4.01%
P/E Ratio-0.1521.0428.0720.05
Price / Sales5.22284.46448.5799.42
Price / CashN/A42.7636.2258.56
Price / Book0.398.378.665.87
Net Income-$5.02M-$55.19M$3.25B$258.55M
7 Day Performance-16.40%5.89%4.20%2.23%
1 Month Performance-28.02%17.63%10.82%12.76%
1 Year Performance-80.16%5.09%34.70%19.36%

Lipella Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LIPO
Lipella Pharmaceuticals
1.7596 of 5 stars
$0.63
-12.9%
N/A-78.8%$2.80M$536.36K-0.154Gap Up
TXMD
TherapeuticsMD
0.435 of 5 stars
$1.15
-1.3%
N/A-36.7%$13.25M$1.84M0.00420Gap Down
CSCI
COSCIENS Biopharma
N/A$4.15
-1.1%
N/AN/A$13.06M$9.59M-0.7120Positive News
Gap Down
ABP
Abpro
N/A$0.21
-5.6%
$4.00
+1,764.8%
N/A$13.04M$180K0.0015Positive News
Gap Up
TRIB
Trinity Biotech
0.8311 of 5 stars
$0.71
-1.3%
N/A-77.5%$12.83M$61.56M-0.24480News Coverage
SNPX
Synaptogenix
0.0429 of 5 stars
$9.21
-8.9%
N/A+130.6%$12.80MN/A-0.914
GOVX
GeoVax Labs
1.8955 of 5 stars
$0.80
-2.0%
$8.88
+1,004.8%
-68.5%$12.80M$3.95M-0.2210Upcoming Earnings
BCDA
BioCardia
3.4971 of 5 stars
$2.25
-3.8%
$25.00
+1,011.1%
-18.7%$12.71M$60K-0.9940Positive News
ATNF
180 Life Sciences
1.0568 of 5 stars
$2.13
-24.4%
N/A-5.3%$12.50MN/A-0.147Positive News
Earnings Report
Gap Up
High Trading Volume
IMCC
IM Cannabis
0.2356 of 5 stars
$3.03
-0.3%
N/A+29.3%$12.24M$39.44M-4.73340Positive News
Gap Down
IBIO
iBio
1.2553 of 5 stars
$0.73
+0.2%
$5.00
+586.8%
-65.8%$12.06M$375K0.00100

Related Companies and Tools


This page (NASDAQ:LIPO) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners